Post-Warning Letter Meetings Under the Generic Drug User Fee Act (GDUFA); Draft Guidance for Industry; Availability

1 organizations filed 1 public comment on Post-Warning Letter Meetings Under the Generic Drug User Fee Act (GDUFA); Draft Guidance for Industry; Availability, at the Food and Drug Administration. The comment window closed 1027d ago.

Abstract

OPEN

Commenters (1)

• Association for Accessible Medicinestrade assoc.

  1 filing · confidence 97%